Skip to main content
. Author manuscript; available in PMC: 2023 Mar 17.
Published in final edited form as: Psychol Aging. 2022 Feb;37(1):43–50. doi: 10.1037/pag0000653

Table 1.

World Health Organization “Good Clinical Practice” Principles: Implementation in ACTIVE and Single-Lab Studies

WHO Principle # and Description Example Implementation in ACTIVE Proposed Implementation in Single-Lab Studies
2. Research involving humans should be scientifically justified and described in a clear, detailed protocol - Manual of Procedures (MOP)
- Scientific rationale in MOP and introduction of design paper
- Predefined analysis plans
- Lab Manual
- Scientific rationale included in Lab Manual and/or Registered Report
- Pre-defined analysis plans
- Methods sections make transparent details of data collection and analysis
6. Research involving humans should be conducted in compliance with the approved protocol; - Full protocol conducted in compliance with approved protocol
- Detailed data management protocol, detailed manuals and scripts, standardized data forms
- Communication log book
- Conduct full protocol in compliance with approved protocol
- Detailed data management protocol, detailed manuals and scripts, standardized data forms
- Communication channels, electronic lab notebooks, or study folder
- Tablet and Computer-based Instruction
10. Each individual involved in conducting a trial should be qualified by education, training, and experience to perform his or her respective task(s) and currently licensed to do so, where required; - Rigorous training and certification/recertification procedures for all roles (assessment, intervention, data, coordination, test scoring; special certification for clinical procedures such as BMI, hand dynamometer, physical performance tests), checklists - Rigorous training and certification/recertification procedures for all roles, checklists
11. All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting, interpretation, and verification; - Publicly available MOP, instruments, and data (via NACDA)
- Separation of data analysis role (coordinating center analysts) from PIs
- DSMB reviews interim data
- Pre-approval and post-review of all presentations and papers
- Make Lab Manual, instruments, data, and code publicly available
- Separation of data analysis role (independent statistician); “buddy system” to check data analyses; or within-institution informal data management and oversight
- Multiverse analyses, specification curves
14. Systems with procedures that assure the quality of every aspect of the trial should be implemented. - Regular quality assurance observations (assessment, intervention, data management), including by outside parties (coordinating center, DSMB, funding agency)
- 10% quality checks of all test scoring
- Standardized equipment and calibration
- Regular quality assurance (utilizing checklists)
- Quality checks of test and/or questionnaire scoring
- Use measures for which online training and certification are available

Note. DSMB = Data safety and monitoring board; MOP = Manual of procedures; NACDA = National Archive of Computerized Data in Aging; PI = Principal Investigator; WHO = World Health Organization